RenBio, Inc.
RenBio, Inc., a leading biotechnology firm headquartered in the United States, has been at the forefront of innovative solutions since its inception in 2015. With a strong focus on developing advanced therapeutics and diagnostics, RenBio operates primarily in the biopharmaceutical sector, catering to a diverse range of medical needs. The company is renowned for its proprietary platform that harnesses the power of biologics to create unique treatments for various diseases. RenBio's commitment to research and development has positioned it as a key player in the industry, achieving significant milestones in clinical trials and product launches. With a growing portfolio of core products, RenBio continues to make strides in enhancing patient outcomes and advancing healthcare solutions globally.
DitchCarbon Score
How does RenBio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RenBio, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RenBio, Inc.'s reported carbon emissions
RenBio, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that RenBio may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate accountability. Without specific emissions figures or reduction strategies, it is unclear how RenBio, Inc. aligns with industry standards for climate action. The absence of reported data highlights a potential area for improvement in transparency and commitment to sustainability within the organisation.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RenBio, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
